Athersys
Presence
Athersys is a company listed under the stock ticker ATHX (US).
Executives
View the org chart displaying its 15 main executives
Most searched biographies at Athersys
Popular executive movements at Athersys
- Jane Wasman, who was Director, is promoted to Chairman of the Board (posted on October 3 2023).
- Neema Mayhugh has joined the company as Director (posted on August 13 2023).
Create your alert
to follow the executive moves at Athersys.
Biotechnology
Athersys has 2,274 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Bruker has announced the acquisition of NanoString Technologies (posted on April 18 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (posted on April 16 2024).
- Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).
Popular contacts in Biotechnology
News
Press releases by Athersys
- Athersys, Inc. Announces Pricing of $3.5 Million Public Offering
- Athersys Reports Second Quarter 2023 Financial Results and Business Highlights
- Athersys Appoints Neema Mayhugh, PhD to its Board of Directors
- Athersys to Host Business Update Conference Call on August 9th
- Patient Enrollment Begins in Third and Final Cohort of the Phase 2 MATRICS-1 Clinical Study Evaluating Athersys’ MultiStem® Following Hemorrhagic Trauma
- Athersys Restructures Debt with Supplier
- Athersys, Inc. - News & Media - Social Media
- Athersys, Inc. - News & Media - Video
- Athersys, Inc. - News & Media - In the News
- Athersys, Inc. - News & Media
- View more press releases Close
Social media about Athersys
- Athersys on Wikipedia, Google News & Yahoo Finance
- Athersys on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Maia Hansen 
